{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:45:11Z","timestamp":1793303111486,"version":"4.5.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ncl.2024.12.008","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:09:10Z","timestamp":1737551350000},"page":"291-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Non-motor Symptoms and Treatments in Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Jennifer G.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ncl.2019.12.003","article-title":"Treatment of nonmotor symptoms associated with Parkinson disease","volume":"38","author":"Goldman","year":"2020","journal-title":"Neurol Clin"},{"issue":"9996","key":"10.1016\/j.ncl.2024.12.008_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2024.12.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2023.08.012","article-title":"Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson's disease","volume":"174","author":"Qamar","year":"2024","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/08919887231164358","article-title":"A\u00a0prescription for wellness in early PD: just what the doctor ordered","volume":"36","author":"McDaniels","year":"2023","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.008_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jagp.2023.02.049","article-title":"A\u00a0wellness prescription for Parkinson's: mid to late-stage disease","volume":"31","author":"Pontone","year":"2023","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14737175.2019.1561285","article-title":"Multidisciplinary care for people with Parkinson's disease: the new kids on the block","volume":"19","author":"Radder","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"10423","key":"10.1016\/j.ncl.2024.12.008_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib11","first-page":"135","article-title":"Delivering multidisciplinary rehabilitation care in Parkinson's disease: an international consensus statement","volume":"14","author":"Goldman","year":"2024","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.irn.2017.05.018","article-title":"Nonmotor symptoms in experimental models of Parkinson's disease","volume":"133","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mds.10262","article-title":"Resource use and costs in a Swedish cohort of patients with Parkinson's disease","volume":"17","author":"Hagell","year":"2002","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","article-title":"Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected","volume":"14","author":"Todorova","year":"2014","journal-title":"Pract Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib19","article-title":"The impact of nonmotor symptoms on health-related quality of life in Parkinson's disease: a network analysis approach","volume":"12","author":"Heimrich","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib20","doi-asserted-by":"crossref","first-page":"e28643","DOI":"10.1097\/MD.0000000000028643","article-title":"Gender differences in motor and non-motor symptoms in early Parkinson disease","volume":"101","author":"Kang","year":"2022","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib21","article-title":"Sex differences in motor and non-motor symptoms among Spanish patients with Parkinson's disease","volume":"12","author":"Santos-Garc\u00eda","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ncl.2024.12.008_bib22","doi-asserted-by":"crossref","first-page":"1339716","DOI":"10.3389\/fneur.2024.1339716","article-title":"Age and gender differences in non-motor symptoms in people with Parkinson's disease","volume":"15","author":"Maas","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/bs.irn.2017.05.032","article-title":"Nonmotor symptoms in Parkinson's disease: gender and ethnic differences","volume":"133","author":"Sauerbier","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib24","first-page":"1639","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson's disease","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2024.12.008_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2012.07.026","article-title":"Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease","volume":"323","author":"Solla","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib26","first-page":"1583","article-title":"The relevance of gender in Parkinson's disease: a review","volume":"264","author":"Picillo","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2016.04.001","article-title":"Gender and non motor fluctuations in Parkinson's disease: a prospective study","volume":"27","author":"Picillo","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2024.12.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478702","article-title":"Non-motor symptoms assessed by non-motor symptoms questionnaire and non-motor symptoms scale in Parkinson's disease in selected asian populations","volume":"49","author":"Sauerbier","year":"2017","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib29","first-page":"281","article-title":"Impact of ethnicity on non-motor symptoms of Parkinson's disease","volume":"2","author":"Rana","year":"2012","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib30","first-page":"299","article-title":"Clinical non-motor phenotyping of Black and asian minority ethnic compared to white individuals with Parkinson's disease living in the United Kingdom","volume":"11","author":"Sauerbier","year":"2021","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.ncl.2024.12.008_bib31","doi-asserted-by":"crossref","first-page":"591183","DOI":"10.3389\/fnagi.2020.591183","article-title":"Profiling non-motor symptoms in monogenic Parkinson's disease","volume":"12","author":"Liu","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ncl.2024.12.008_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.irn.2017.05.030","article-title":"Nonmotor signs in genetic forms of Parkinson's disease","volume":"133","author":"Kasten","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ncl.2024.12.008_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-024-02833-8","article-title":"Non-motor symptoms of Parkinson`s disease-insights from genetics","author":"Jer\u010di\u0107","year":"2024","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"7954","key":"10.1016\/j.ncl.2024.12.008_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","article-title":"\"On-off\" effects in patients with Parkinson's disease on chronic levodopa therapy","volume":"1","author":"Marsden","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2024.12.008_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/bs.irn.2017.05.021","article-title":"Nonmotor fluctuations in Parkinson's disease","volume":"134","author":"Franke","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ncl.2024.12.008_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2014.10.006","article-title":"Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients","volume":"127","author":"Brun","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib37","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"issue":"s2","key":"10.1016\/j.ncl.2024.12.008_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2008.02212.x","article-title":"Quantitation of non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Chaudhuri","year":"2008","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mds.27862","article-title":"The movement disorder society nonmotor rating scale: initial validation study","volume":"35","author":"Chaudhuri","year":"2020","journal-title":"Mov Disord"},{"issue":"15","key":"10.1016\/j.ncl.2024.12.008_bib40","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib41","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/mds.28507","article-title":"Non-motor fluctuations in Parkinson's disease: validation of the non-motor fluctuation assessment questionnaire","volume":"36","author":"Kleiner","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107036","article-title":"Non-motor symptoms in PD evaluated during pharmacological ON state by a new tool: the NoMoS-ON scale. Is always the \"ON\" state beneficial?","volume":"125","author":"Donzuso","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000002898","article-title":"Detecting depression in Parkinson disease: a systematic review and meta-analysis","volume":"87","author":"Goodarzi","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib45","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/mdc3.14163","article-title":"Improving Parkinson's disease care through systematic screening for depression","volume":"11","author":"Marras","year":"2024","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/00207454.2012.751024","article-title":"Quality care assessment of Parkinson's disease at a tertiary medical center","volume":"123","author":"Baek","year":"2013","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610219000048","article-title":"Improved understanding, detection, and management of neuropsychiatric complications: essential components to the optimal treatment of Parkinson's disease","volume":"31","author":"Dobkin","year":"2019","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.parkreldis.2015.03.024","article-title":"Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease","volume":"21","author":"Martinez-Martin","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/jamaneurol.2023.4207","article-title":"Risk of suicidal ideation and behavior in individuals with Parkinson disease: a systematic review and meta-analysis","volume":"81","author":"Mai","year":"2024","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","article-title":"Anxiety disorders in Parkinson's disease: prevalence and risk factors","volume":"25","author":"Dissanayaka","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2018.04.020","article-title":"Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease","volume":"54","author":"Kim","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mds.24041","article-title":"Parkinson's disease motor subtypes and mood","volume":"27","author":"Burn","year":"2012","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson's disease: a systematic review and meta-analysis","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib54","article-title":"Management of psychiatric and cognitive complications in Parkinson's disease","volume":"379","author":"Weintraub","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib55","first-page":"7330","article-title":"German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions","volume":"271","author":"Kalbe","year":"2024","journal-title":"J\u00a0Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib56","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A\u00a0controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib58","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.parkreldis.2013.02.018","article-title":"Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER","volume":"19","author":"Chaudhuri","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320985993","article-title":"The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson's disease: meta-analysis of randomized controlled trials","volume":"11","author":"Huang","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.ncl.2024.12.008_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2020.10.020","article-title":"A\u00a0trial of buspirone for anxiety in Parkinson's disease: safety and tolerability","volume":"81","author":"Schneider","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib62","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jagp.2016.08.017","article-title":"Neuropsychiatric complications of Parkinson disease treatments: importance of multidisciplinary care","volume":"24","author":"Taylor","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.ncl.2024.12.008_bib63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/NDT.S152221","article-title":"Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson's disease","volume":"14","author":"Berardelli","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib64","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/gps.5077","article-title":"Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease","volume":"34","author":"Dobkin","year":"2019","journal-title":"Int J Geriatr Psychiatr"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib65","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/mds.28548","article-title":"Innovating Parkinson's care: a randomized controlled trial of telemedicine depression treatment","volume":"36","author":"Dobkin","year":"2021","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.ncl.2024.12.008_bib66","doi-asserted-by":"crossref","first-page":"e1764","DOI":"10.1212\/WNL.0000000000009292","article-title":"Telephone-based cognitive behavioral therapy for depression in Parkinson disease: a randomized controlled trial","volume":"94","author":"Dobkin","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib67","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/mds.28533","article-title":"Cognitive behavioral therapy for anxiety in Parkinson's disease: a randomized controlled trial","volume":"36","author":"Moonen","year":"2021","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/07317115.2016.1240131","article-title":"Cognitive behavior therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers","volume":"40","author":"Dissanayaka","year":"2017","journal-title":"Clin Gerontol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib69","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00702-019-02019-7","article-title":"Neuropsychiatric aspects of Parkinson's disease","volume":"126","author":"Nagy","year":"2019","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib70","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamaneurol.2019.0534","article-title":"Effects of mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with Parkinson disease: a randomized clinical trial","volume":"76","author":"Kwok","year":"2019","journal-title":"JAMA Neurol"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2024.12.008_bib71","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain : J Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib72","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","article-title":"The epidemiology of dementia associated with Parkinson's disease","volume":"20","author":"Aarsland","year":"2010","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib75","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209699","article-title":"Long-term dementia risk in Parkinson disease","volume":"103","author":"Gallagher","year":"2024","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.008_bib76","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/mds.28115","article-title":"Subjective cognitive complaint in Parkinson's disease patients with normal cognition: canary in the coal mine?","volume":"35","author":"Purri","year":"2020","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0891988714532015","article-title":"Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?","volume":"27","author":"Erro","year":"2014","journal-title":"J\u00a0Geriatr Psychiatr Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib78","article-title":"Subjective cognitive decline in patients with Parkinson's disease: an updated review","volume":"15","author":"Huang","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mds.29649","article-title":"Subjective cognitive complaints in Parkinson's disease: a systematic review and meta-analysis","volume":"39","author":"Siciliano","year":"2024","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13548506.2018.1510131","article-title":"Caregiver burden and family functioning in different neurological diseases","volume":"24","author":"Tramonti","year":"2019","journal-title":"Psychol Health Med"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A\u00a0biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A\u00a0biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"Hoglinger","year":"2024","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib85","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1111\/ene.15481","article-title":"Systematic review of data-driven cognitive subtypes in Parkinson disease","volume":"29","author":"Pourzinal","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/awz311","article-title":"Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework","volume":"143","author":"Matar","year":"2020","journal-title":"Brain : J Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib87","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib88","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.27233","article-title":"Global scales for cognitive screening in Parkinson's disease: critique and recommendations","volume":"33","author":"Skorvanek","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib90","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.25873","article-title":"Psychiatric issues in cognitive impairment","volume":"29","author":"Aarsland","year":"2014","journal-title":"Mov Disord"},{"issue":"14","key":"10.1016\/j.ncl.2024.12.008_bib91","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: a prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk factors for non-motor symptoms in Parkinson's disease","volume":"17","author":"Marinus","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib94","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mds.24939","article-title":"Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.26312","article-title":"Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson's disease?","volume":"31","author":"Duncan","year":"2016","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.12111280","article-title":"Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging","volume":"263","author":"Seibert","year":"2012","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib98","doi-asserted-by":"crossref","first-page":"561-e20","DOI":"10.1111\/ene.13258","article-title":"Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature","volume":"24","author":"Fagan","year":"2017","journal-title":"Eur J Neurol"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2024.12.008_bib99","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson's disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2024.12.008_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105511","article-title":"Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6\/5-HT2A antagonist, for the treatment of Parkinson disease dementia: a randomized, controlled, proof-of-concept trial","volume":"114","author":"Fernandez","year":"2023","journal-title":"Park Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib101","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mds.28879","article-title":"Safety and efficacy of mevidalen in Lewy body dementia: a phase 2, randomized, placebo-controlled trial","volume":"37","author":"Biglan","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105367","article-title":"A\u00a0randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease","volume":"110","author":"Kulisevsky","year":"2023","journal-title":"Park Relat Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2017.3762","article-title":"Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia: a randomized clinical trial","volume":"75","author":"Gratwicke","year":"2018","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.008_bib104","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1017\/S135561771600076X","article-title":"Aerobic exercise improves mood, cognition, and language function in Parkinson's disease: results of a controlled study","volume":"22","author":"Altmann","year":"2016","journal-title":"J\u00a0Int Neuropsychol Soc : JINS"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib105","first-page":"25","article-title":"Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial","volume":"31","author":"Picelli","year":"2016","journal-title":"Funct Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/acm.2018.0413","article-title":"Sardinian folk dance for individuals with Parkinson's disease: a randomized controlled pilot trial","volume":"25","author":"Solla","year":"2019","journal-title":"J\u00a0Altern Complement Med"},{"key":"10.1016\/j.ncl.2024.12.008_bib107","article-title":"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson\u2019s disease","volume":"2","author":"Orgeta","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib108","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A\u00a012-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib110","first-page":"541","article-title":"Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson's disease","volume":"5","author":"Alvarado-Bolanos","year":"2015","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.22839","article-title":"The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria","volume":"25","author":"Fenelon","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105208","article-title":"Understanding visual hallucinations: a new synthesis","volume":"150","author":"Collerton","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae358","article-title":"Functional and connectivity correlates associated with Parkinson's disease psychosis: a systematic review","volume":"6","author":"Pisani","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.ncl.2024.12.008_bib114","article-title":"Examining agreement in psychotic symptom assessment: insights from Parkinson's disease dementia dyads","author":"Beehler","year":"2024","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib115","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.21875","article-title":"Scales to assess psychosis in Parkinson's disease: critique and recommendations","volume":"23","author":"Fernandez","year":"2008","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib116","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parkreldis.2012.10.022","article-title":"Performance of a shortened scale for assessment of positive symptoms for Parkinson's disease psychosis","volume":"19","author":"Voss","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib117","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/jnnp.2008.153163","article-title":"Impact of standard of care for psychosis in Parkinson disease","volume":"79","author":"Thomsen","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib118","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200175","article-title":"Ulotaront, a trace amine-associated receptor 1\/serotonin 5-HT(1A) agonist, in patients with Parkinson disease psychosis: a pilot study","volume":"13","author":"Isaacson","year":"2023","journal-title":"Neurol Clin Pract"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","article-title":"Cholinesterase inhibitors for treatment of psychotic symptoms in alzheimer disease and Parkinson disease: a meta-analysis","volume":"80","author":"d'Angremont","year":"2023","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.10450","article-title":"Coping strategies for visual hallucinations in Parkinson's disease","volume":"18","author":"Diederich","year":"2003","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib121","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib122","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209301","article-title":"Cross-sectional and longitudinal association of clinical and neurocognitive factors with apathy in patients with Parkinson disease","volume":"102","author":"Le Heron","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib123","first-page":"2798","article-title":"Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson's disease","volume":"271","author":"Maggi","year":"2024","journal-title":"J\u00a0Neurol"},{"issue":"26","key":"10.1016\/j.ncl.2024.12.008_bib124","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029766","article-title":"Apathy and impulsiveness in Parkinson disease: two faces of the same coin?","volume":"101","author":"Palmeri","year":"2022","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson's disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci. Spring"},{"key":"10.1016\/j.ncl.2024.12.008_bib126","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib127","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2024.12.008_bib130","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neubiorev.2019.09.041","article-title":"Neural bases of impulse control disorders in Parkinson's disease: a systematic review and an ALE meta-analysis","volume":"107","author":"Santangelo","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2016.12.070","article-title":"Dopamine agonist withdrawal syndrome: a comprehensive review","volume":"374","author":"Yu","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2024.12.008_bib133","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2017.01.019","article-title":"Management of impulse control disorders with deep brain stimulation: a double-edged sword","volume":"374","author":"Kasemsuk","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.008_bib134","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","article-title":"Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","volume":"83","author":"Papay","year":"2014","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib135","first-page":"4851","article-title":"Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial","volume":"270","author":"Laurencin","year":"2023","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib136","article-title":"Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline \"Parkinson's disease\" of the German Society of Neurology","author":"Witt","year":"2024","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib137","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cger.2019.09.005","article-title":"Overview of sleep and circadian rhythm disorders in Parkinson disease","volume":"36","author":"Gros","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib138","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"Hogl","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-017-0795-4","article-title":"Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.01.018","article-title":"Clinical progression in Parkinson's disease with features of REM sleep behavior disorder: a population-based longitudinal study","volume":"62","author":"Duarte Folle","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib141","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5664\/jcsm.2670","article-title":"Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample","volume":"9","author":"Boeve","year":"2013","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib142","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.25438","article-title":"Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease","volume":"28","author":"Chahine","year":"2013","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.ncl.2024.12.008_bib143","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib144","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mds.24909","article-title":"Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease","volume":"27","author":"Di Giacopo","year":"2012","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad103","article-title":"Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder","volume":"46","author":"During","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.ncl.2024.12.008_bib146","article-title":"Chronic insomnia in patients with Parkinson disease: which associated factors are relevant?","author":"Sobreira-Neto","year":"2019","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib147","first-page":"577","article-title":"[A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep]","volume":"43","author":"Martinez-Martin","year":"2006","journal-title":"Rev Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib148","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.23476","article-title":"Parkinson's disease sleep scale--validation of the revised version PDSS-2","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib149","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41531-017-0027-z","article-title":"Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series","volume":"3","author":"Humbert","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ncl.2024.12.008_bib150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib151","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-2018.2012.00711.x","article-title":"Effect of cognitive behavior therapy on sleep disorder in Parkinson's disease in China: a pilot study","volume":"14","author":"Yang","year":"2012","journal-title":"Nurs Health Sci"},{"key":"10.1016\/j.ncl.2024.12.008_bib152","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.sleep.2021.03.035","article-title":"The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"83","author":"Lin","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.ncl.2024.12.008_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102474","article-title":"Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial","volume":"69","author":"Feigl","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib154","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.sleep.2015.05.028","article-title":"Natural course of restless legs syndrome\/Willis-Ekbom disease: long-term observation of a large clinical cohort","volume":"16","author":"Mitterling","year":"2015","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-019-0965-4","article-title":"Update on restless legs syndrome: from mechanisms to treatment","volume":"19","author":"Gonzalez-Latapi","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib156","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11539720-000000000-00000","article-title":"Excessive daytime sleepiness in patients with Parkinson's disease","volume":"25","author":"Knie","year":"2011","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib157","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.0000000000001737","article-title":"Development of excessive daytime sleepiness in early Parkinson disease","volume":"85","author":"Tholfsen","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.008_bib158","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2024.12.008_bib159","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fneur.2019.00121","article-title":"Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease","volume":"10","author":"Xiang","year":"2019","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","article-title":"Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial","volume":"74","author":"Videnovic","year":"2017","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.008_bib161","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/mds.28702","article-title":"Solriamfetol for excessive daytime sleepiness in Parkinson's disease: phase 2 proof-of-concept trial","volume":"36","author":"Videnovic","year":"2021","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib162","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamaneurol.2017.3171","article-title":"Sodium oxybate for excessive daytime sleepiness and sleep disturbance in Parkinson disease: a randomized clinical trial","volume":"75","author":"B\u00fcchele","year":"2018","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib163","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib164","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.02.041","article-title":"Slave to the rhythm: seasonal differences in non-motor symptoms in Parkinson's disease","volume":"63","author":"van Wamelen","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-019-02039-3","article-title":"Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide","volume":"126","author":"Baumann","year":"2019","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib166","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12264-016-0089-7","article-title":"A\u00a0new perspective for Parkinson's disease: circadian rhythm","volume":"33","author":"Li","year":"2017","journal-title":"Neurosci Bull"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib167","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib168","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson's disease: an update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.07.008","article-title":"Longitudinal assessment of autonomic dysfunction in early Parkinson's disease","author":"Stankovic","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib171","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00702-016-1594-6","article-title":"Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease","volume":"123","author":"Umehara","year":"2016","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib172","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10072-022-06537-3","article-title":"A\u00a0systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease","volume":"44","author":"Loureiro","year":"2023","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib173","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib174","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib175","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib176","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/21681805.2021.1990994","article-title":"The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trial","volume":"56","author":"Moussa","year":"2022","journal-title":"Scand J Urol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib177","article-title":"A\u00a0novel trial of mirabegron and behavioral modification including pelvic floor exercise for overactive bladder in Parkinson's disease (MAESTRO)","volume":"14","author":"Madan","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.008_bib178","first-page":"960","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib179","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ner.12446","article-title":"The impact of pallidal and subthalamic deep brain stimulation on urologic function in Parkinson's disease","volume":"19","author":"Mock","year":"2016","journal-title":"Neuromodulation"},{"issue":"13","key":"10.1016\/j.ncl.2024.12.008_bib180","doi-asserted-by":"crossref","first-page":"e1427","DOI":"10.1212\/WNL.0000000000008931","article-title":"Bladder training for urinary tract symptoms in Parkinson disease: a randomized controlled trial","volume":"94","author":"McDonald","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib181","first-page":"7","article-title":"The frequency and severity of gastrointestinal symptoms in patients with early Parkinson's disease","volume":"7","author":"Sung","year":"2014","journal-title":"J\u00a0Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib183","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib184","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2016.05.016","article-title":"Constipation and risk of Parkinson's disease: a Danish population-based cohort study","volume":"28","author":"Svensson","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib186","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","article-title":"Probiotics for constipation and gut microbiota in Parkinson's disease","volume":"103","author":"Du","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"21","key":"10.1016\/j.ncl.2024.12.008_bib187","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease","volume":"78","author":"Ondo","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.008_bib188","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.7326\/M22-1438","article-title":"Oral ENT-01 targets enteric neurons to treat constipation in Parkinson disease : a randomized controlled trial","volume":"175","author":"Camilleri","year":"2022","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib189","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.parkreldis.2012.01.001","article-title":"Apomorphine injections: predictors of initial common adverse events and long term tolerability","volume":"18","author":"Ondo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106982","article-title":"Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease","volume":"124","author":"Safarpour","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib191","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2019.04.014","article-title":"Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's","volume":"64","author":"Hurt","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib192","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2016.07.058","article-title":"Abnormal sexuality in Parkinson's disease: fact or fancy?","volume":"369","author":"Ferrucci","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib193","first-page":"2433","article-title":"Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease","volume":"262","author":"Deng","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib194","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.12561","article-title":"The role of sex therapy in the management of patients with Parkinson's disease","volume":"5","author":"Bronner","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib195","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib196","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jnr.23729","article-title":"Sensory symptoms in Parkinson's disease: clinical features, pathophysiology, and treatment","volume":"94","author":"Zhu","year":"2016","journal-title":"J\u00a0Neurosci Res"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.008_bib197","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.24054","article-title":"Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool","volume":"27","author":"Broen","year":"2012","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib198","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","article-title":"Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease","volume":"80","author":"Schrag","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2024.12.008_bib199","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.3568","article-title":"Hearing loss, incident Parkinson disease, and treatment with hearing aids","author":"Neilson","year":"2024","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.008_bib200","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.10734","article-title":"Longitudinal changes in hearing and visual impairments and risk of dementia in older adults in the United States","volume":"5","author":"Hwang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.008_bib201","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1007\/s10571-023-01419-4","article-title":"Retinal changes in Parkinson's disease: a non-invasive biomarker for early diagnosis","volume":"43","author":"Subramaniam","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.008_bib202","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2024.12.008_bib203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2047-783X-19-29","article-title":"Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson's disease","volume":"19","author":"Sun","year":"2014","journal-title":"Eur J Med Res"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.008_bib204","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1037\/neu0000276","article-title":"Impaired perception of biological motion in Parkinson's disease","volume":"30","author":"Jaywant","year":"2016","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.008_bib205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1444-0938.2007.00211.x","article-title":"Visual signs and symptoms of Parkinson's disease","volume":"91","author":"Armstrong","year":"2008","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.008_bib206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-709X-20-31","article-title":"What is the prevalence of musculoskeletal problems in the elderly population in developed countries? A systematic critical literature review","volume":"20","author":"Fejer","year":"2012","journal-title":"Chiropr Man Therap"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.008_bib207","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2013.03.002","article-title":"Musculoskeletal problems in Parkinson's disease: neglected issues","volume":"19","author":"Kim","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.008_bib208","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clineuro.2017.12.011","article-title":"Predictive risk factors for chronic low back pain in Parkinson's disease","volume":"164","author":"Ozturk","year":"2018","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861924001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861924001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:55:38Z","timestamp":1750776938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861924001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":208,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0733861924001038"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2024.12.008","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-motor Symptoms and Treatments in Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2024.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}